Zoe J. Assaf - Concepedia

Author

Zoe J. Assaf

Also Known As

Z. Assaf, Z.J. Assaf, Z.J.F. Assaf, Zoe June Assaf, Zoe Assaf, Zoe J Assaf, Zoe J. Assaf, Zoe June Assaf, Zoe June F. Assaf, Zoe June Assaf

102

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Natera (United States)Queen Mary University of London Foundation Medicine (United States)Roche (Canada)Roche (Switzerland)

About

Zoe J. Assaf is an author at Natera (United States) specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	757
2	Health Sciences	2	2	141
3	Natural Sciences	2	2	177
4	Biology	2	2	88
5	Cell Biology	1	1	32

Zoe J. Assaf

Publications

Citations

H-Index

Page 1

	Year	Citations
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer Thomas Reinert, Tenna Vesterman Henriksen, Emil Christensen, JAMA Oncology	2019	944
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma Thomas Powles, Zoe J. Assaf, Nicole N. Davarpanah, Nature Adjuvant ImmunotherapyCancer ImmunosurveillanceUrologyGenitourinary Cancer	2021	578
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma Emil Christensen, Karin Birkenkamp‐Demtröder, Himanshu Sethi, Journal of Clinical Oncology	2019	518
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence R. Charles Coombes, Karen Page, Raheleh Salari, Clinical Cancer Research	2019	481
Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study Arnon P. Kater, Jenny Wu, Thomas J. Kipps, Journal of Clinical Oncology	2020	209
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder Bernadett Szabados, Mark Kockx, Zoe J. Assaf, European Urology UrologyGenitourinary CancerMuscle-invasive Urothelial CancerMedicineCancer Treatment	2022	175
Molecular determinants of response to PD-L1 blockade across tumor types Romain Banchereau, Ning Leng, Oliver A. Zill, Nature Communications	2021	165
Pairing Centers Recruit a Polo-like Kinase to Orchestrate Meiotic Chromosome Dynamics in C. elegans Nicola C. Harper, Regina Rillo, Sara Jover‐Gil, Developmental Cell ChromatinChromosome DynamicsDevelopmental BiologyChromatin StructureCell Division	2011	145
A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer Zoe J. Assaf, Wei Zou, Alexander D. Fine, Nature Medicine Ctdna AssessmentsPathologyCancer RegistrationEarly CtdnaTumor Biology	2023	127
Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma Thomas Powles, Zoe J. Assaf, Viraj Degaonkar, European Urology UrologyOverall SurvivalGenitourinary CancerImvigor010 TrialMedicine	2023	112

Page 1